Punit Marathe

4.4k total citations
47 papers, 1.6k citations indexed

About

Punit Marathe is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Punit Marathe has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Pediatrics, Perinatology and Child Health and 14 papers in Pharmacology. Recurrent topics in Punit Marathe's work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Punit Marathe is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Punit Marathe collaborates with scholars based in United States, Germany and United Kingdom. Punit Marathe's co-authors include Hong Shen, Christopher R. Gibson, M. Sherry Ku, Kimberly K. Adkison, Vikash K. Sinha, Thierry Lavé, Volker Fischer, Rhys D.O. Jones, Barbara J. Ring and Thorir D. Bjornsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Punit Marathe

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Punit Marathe United States 23 816 613 399 351 201 47 1.6k
Jane R. Kenny United States 24 707 0.9× 996 1.6× 442 1.1× 192 0.5× 237 1.2× 58 1.8k
Donald Tweedie United States 24 568 0.7× 834 1.4× 499 1.3× 230 0.7× 158 0.8× 49 1.6k
Chuang Lu United States 23 748 0.9× 1.1k 1.8× 659 1.7× 250 0.7× 305 1.5× 56 2.3k
Liang‐Shang Gan United States 25 953 1.2× 759 1.2× 843 2.1× 379 1.1× 223 1.1× 43 2.4k
Charles J. Rotter United States 17 613 0.8× 367 0.6× 474 1.2× 278 0.8× 219 1.1× 25 1.3k
A. David Rodrigues United States 26 772 0.9× 924 1.5× 416 1.0× 328 0.9× 155 0.8× 49 1.8k
Handan He United States 26 485 0.6× 591 1.0× 411 1.0× 187 0.5× 280 1.4× 54 1.8k
Larry M. Tremaine United States 24 731 0.9× 932 1.5× 319 0.8× 381 1.1× 225 1.1× 48 1.8k
Matthew G. Soars United States 20 785 1.0× 979 1.6× 378 0.9× 288 0.8× 128 0.6× 32 1.6k
Katherine S. Fenner United Kingdom 20 1.0k 1.3× 619 1.0× 337 0.8× 483 1.4× 171 0.9× 28 1.7k

Countries citing papers authored by Punit Marathe

Since Specialization
Citations

This map shows the geographic impact of Punit Marathe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Punit Marathe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Punit Marathe more than expected).

Fields of papers citing papers by Punit Marathe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Punit Marathe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Punit Marathe. The network helps show where Punit Marathe may publish in the future.

Co-authorship network of co-authors of Punit Marathe

This figure shows the co-authorship network connecting the top 25 collaborators of Punit Marathe. A scholar is included among the top collaborators of Punit Marathe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Punit Marathe. Punit Marathe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khandelwal, Purnima, et al.. (2021). Pharmacokinetics of 40 kDa Polyethylene glycol (PEG) in mice, rats, cynomolgus monkeys and predicted pharmacokinetics in humans. European Journal of Pharmaceutical Sciences. 165. 105928–105928. 3 indexed citations
2.
Chen, Weiqi, Yueping Zhang, Michael Sinz, et al.. (2019). Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A. Drug Metabolism and Disposition. 47(11). 1352–1360. 15 indexed citations
3.
Morse, Bridget L., Anthony M. Marino, Yue Zhao, et al.. (2017). Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys. The AAPS Journal. 19(6). 1878–1889. 11 indexed citations
4.
Shen, Hong, David M. Nelson, Regina V. Oliveira, et al.. (2017). Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys. Drug Metabolism and Disposition. 46(2). 178–188. 38 indexed citations
5.
Morse, Bridget L., Hong Cai, Lisa Zhang, et al.. (2015). Rosuvastatin Liver Partitioning in Cynomolgus Monkeys: Measurement In Vivo and Prediction Using In Vitro Monkey Hepatocyte Uptake. Drug Metabolism and Disposition. 43(11). 1788–1794. 22 indexed citations
6.
Shen, Hong, Bridget L. Morse, Yue Zhao, et al.. (2015). Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression. Drug Metabolism and Disposition. 43(7). 984–993. 72 indexed citations
7.
Subramanian, Murali, Matthew G. Soars, John J. Herbst, et al.. (2014). A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model. Drug Metabolism Letters. 8(2). 109–118. 16 indexed citations
8.
Subramanian, Murali, Sheelendra Pratap Singh, Sonia Pahwa, et al.. (2013). Characterization of Recombinantly Expressed Rat and Monkey Intestinal Alkaline Phosphatases: In Vitro Studies and In Vivo Correlations. Drug Metabolism and Disposition. 41(7). 1425–1432. 6 indexed citations
9.
Mariappan, T. Thanga, Sandhya Mandlekar, & Punit Marathe. (2013). Insight into Tissue Unbound Concentration: Utility in Drug Discovery and Development. Current Drug Metabolism. 14(3). 324–340. 27 indexed citations
10.
Chimalakonda, Anjaneya, Rajbharan Yadav, & Punit Marathe. (2013). Factors Influencing Magnitude and Duration of Target Inhibition Following Antibody Therapy: Implications in Drug Discovery and Development. The AAPS Journal. 15(3). 717–727. 10 indexed citations
11.
Jones, Rhys D.O., Hannah M. Jones, Malcolm Rowland, et al.. (2011). PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution. Journal of Pharmaceutical Sciences. 100(10). 4074–4089. 104 indexed citations
12.
Poulin, Patrick, Rhys D.O. Jones, Hannah M. Jones, et al.. (2011). PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach. Journal of Pharmaceutical Sciences. 100(10). 4127–4157. 132 indexed citations
13.
Vuppugalla, Ragini, Punit Marathe, Handan He, et al.. (2011). PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach. Journal of Pharmaceutical Sciences. 100(10). 4111–4126. 49 indexed citations
14.
Behnia, Kamelia, Georgia Cornelius, Jian Wang, et al.. (2011). Estimation of the Extent ofin VivoFormation of a Mutagenic Aromatic Amine from a Potent Thyromimetic Compound: Correlation ofin Vitroandin VivoFindings. Chemical Research in Toxicology. 24(6). 905–912. 2 indexed citations
15.
Marathe, Punit, Bogdan Sleczka, David Rodrigues, et al.. (2010). Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2. Journal of Pharmaceutical Sciences. 99(8). 3579–3593. 16 indexed citations
16.
Ruan, Qian, et al.. (2008). A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile. Journal of Pharmaceutical and Biomedical Analysis. 47(2). 351–359. 16 indexed citations
17.
Mastalerz, Harold, Ming Chang, Ashvinikumar V. Gavai, et al.. (2007). Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 17(10). 2828–2833. 24 indexed citations
18.
Huang, Christine, Ming Zheng, Zheng Yang, A. David Rodrigues, & Punit Marathe. (2007). Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been?. Pharmaceutical Research. 25(4). 713–726. 16 indexed citations
19.
Marathe, Punit & A. David Rodrigues. (2006). In Vivo Animal Models for Investigating Potential CYP3A- and Pgp-Mediated Drug-Drug Interactions. Current Drug Metabolism. 7(7). 687–704. 23 indexed citations
20.
Timmins, Peter, et al.. (2005). Steady-State Pharmacokinetics of a Novel Extended-Release Metformin Formulation. Clinical Pharmacokinetics. 44(7). 721–729. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026